Outcomes and measurements of randomized controlled trial for traditional Chinese medicine in treatment of endometriosis.
10.19540/j.cnki.cjcmm.20230413.501
- Author:
Zi-Jin WANG
1
;
Wei-Wei SUN
2
;
Ying-Si ZHANG
1
;
Xue WU
3
;
Rui-Xue LIU
4
;
Xing LIAO
3
;
Rui-Hua ZHAO
2
Author Information
1. Graduate School of Beijing University of Chinese Medicine Beijing 100029,China.
2. Guang'anmen Hospital,China Academy of Chinese Medical Sciences Beijing 100053,China.
3. Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
4. China Academy of Chinese Medical Sciences Beijing 100700,China.
- Publication Type:Journal Article
- Keywords:
core outcome set;
endometriosis;
randomized controlled trial;
traditional Chinese medicine
- MeSH:
Female;
Humans;
Medicine, Chinese Traditional;
Endometriosis/complications*;
Quality of Life;
Syndrome;
Drugs, Chinese Herbal/adverse effects*
- From:
China Journal of Chinese Materia Medica
2023;48(16):4521-4528
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to analyze the outcomes and measurements of randomized controlled trial(RCT) for traditional Chinese medicine(TCM) treatment of endometriosis(EM) and provide a basis for the building of the core outcome set(COS) of EM. The RCT for TCM treatment of EM was retrieved from medical literature databases with the time interval from inception to February 3, 2022. The Cochrane risk of bias assessment tool was employed to evaluate the risk of bias of the included RCT, and descriptive analyses of the extracted information were carried out. A total of 519 RCTs were included, with the sample sizes ranging from 28-582 patients and 239 outcome indicators(8 outcome indicators per RCT on average). According to the functional properties, the reported outcome indicators were classified into 7 indicators: clinical efficacy assessment, indicators of clinical symptoms and signs, TCM symptom efficacy indicators, physical and chemical examinations, quality of life, long-term prognosis, and safety events. All the 519 RCTs had problems, such as the lack of differentiation between primary and secondary outcome indicators(1.73% RCTs reported such differen-tiation), poor quality, confused criteria for composite outcome indicators and arbitrary combination of indicators(45 criteria for the single outcome indicator of efficiency), and messy measurements(as many as 18 measurements for TCM symptom score). In addition, as a chronic disease, EM requires long-term management. The outcome indicators vary for the patients in different disease stages, such as EM pain, EM infertility, and post-operative EM, while the specific outcome indicator sets for different EM populations remain to be developed. In addition, the time point of measurement for EM long-term outcomes remains unclear, and the definition of TCM syndromes lacks standards. The RCT for TCM treatment had a variety of problems, such as the lack of differentiation of outcome indicators, confusion in criteria and measurements, lack of specific outcome indicator sets for different EM populations, and unclear time points for long-term outcomes. Therefore, the studies about COS need to be carried out urgently.
